The estimated Net Worth of Charles J. Jr. Link is at least $6.93 Millón dollars as of 18 December 2012. Charles Link owns over 25,000 units of Lumos Pharma Inc stock worth over $4,266,614 and over the last 13 years Charles sold LUMO stock worth over $2,661,500.
Sign up
Charles Link LUMO stock SEC Form 4 insiders trading
Charles has made over 3 trades of the Lumos Pharma Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Charles sold 25,000 units of LUMO stock worth $312,500 on 18 December 2012.
The largest trade Charles's ever made was selling 150,000 units of Lumos Pharma Inc stock on 20 June 2012 worth over $2,349,000. On average, Charles trades about 35,028 units every 36 days since 2011. As of 18 December 2012 Charles still owns at least 1,198,487 units of Lumos Pharma Inc stock.
You can see the complete history of Charles Link stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Charles Link's mailing address?
Charles's mailing address filed with the SEC is C/O NEWLINK GENETICS CORPORATION, 2503 SOUTH LOOP DR., SUITE 5100, AMES, IA, 50010.
Insiders trading at Lumos Pharma Inc
Over the last 13 years, insiders at Lumos Pharma Inc have traded over $6,087,405 worth of Lumos Pharma Inc stock and bought 2,157,996 units worth $15,106,881 . The most active insiders traders include Seed Farm, Inc. Stine, Paul R Edick y Charles J. Jr. Link. On average, Lumos Pharma Inc executives and independent directors trade stock every 257 days with the average trade being worth of $694,335. The most recent stock trade was executed by James E Deerfield Mgmt Iii,... on 6 January 2021, trading 151,723 units of LUMO stock currently worth $3,425,905.
What does Lumos Pharma Inc do?
lumos pharma is an clinical stage biotechnology company focused on developing therapeutics for rare diseases
What does Lumos Pharma Inc's logo look like?
Complete history of Charles Link stock trades at Lumos Pharma Inc
Lumos Pharma Inc executives and stock owners
Lumos Pharma Inc executives and other stock owners filed with the SEC include:
-
Richard J. Hawkins,
CEO & Chairman -
Dr. John C. McKew Ph.D.,
Chief Scientific Officer & Pres -
Carl W. Langren,
Consultant -
Bradley J. Powers J.D.,
Chief Compliance Officer & Gen. Counsel -
Eddie L. Varnado M.B.A.,
VP of Fin. & Corp. Controller -
Eddie L. Varnado,
VP of Fin. & Corp. Controller -
Dr. David B. Karpf B.A., M.D.,
Chief Medical Officer -
Aaron Schuchart B.B.A., CPA, M.B.A.,
Chief Bus. Officer -
Lisa Miller,
Sr. Director of Investor Relations -
Lori D. Lawley CPA,
CFO & Principal Accounting Officer -
Seed Farm, Inc. Stine,
10% owner -
Charles J. Jr. Link,
Chairman of the Board & CEO -
Nicholas N. Vahanian,
Pres, Chief Medical Officer -
Gordon H Jr Link,
Chief Financial Officer -
Paul R Edick,
Director -
Joseph Saluri,
Director -
Ernest Iii Talarico,
Director -
David J. Lundquist,
Director -
Kenneth Lynn,
Exec VP of Bus Development -
Thomas A. Raffin,
Director -
Sarah Alexander,
Director -
William J. Ramsey,
Quality Assurance Officer -
James E Deerfield Mgmt Iii,...,